Key Points:US officially withdraws from WHO, flag removed from Geneva headquartersTrump administration cites COVID-19 pandemic mismanagement as primary reasonApproximately $260 million in membership dues...
New Delhi:The Drugs Controller General of India has approved Itolizumab for restricted emergency use on COVID-19 patients with moderate to severe acute respiratory distress...